Additionally, luteolin induces apoptosis in multidrug-resistant cancer cells by ROS generation, DNA damage initiation, activation of ATR/Chk2/p53 signaling, inhibition of NF-kB signaling, activation of p38, and depletion of anti-apoptotic proteins [133]. The gene discussed is TP53; the disease is cancer.